Evidence map›Paper›PMID 32966041›Full record

ArticleACS infectious diseases2020

The Malaria Metabolite HMBPP Does Not Trigger Erythrocyte Terpene Release.

Justin J Miller, Audrey R Odom John

Open access · greenAbstract read
In one paragraph

Article in ACS infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Justin J MillerDepartment of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, United States.ORCID 0000-0001-9400-8916
Audrey R Odom JohnDepartment of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, United States.ORCID 0000-0001-8395-8537
Children's Hospital of Philadelphia · USWashington University in St. Louis · US

Funding

MEP pathway resistance in Plasmodium falciparumR01AI103280 · NIAID · WASHINGTON UNIVERSITY · PI Audrey Ragan Odom John · 2013 to 2026
$5.5M
Towards noninvasive diagnosis of malariaR21AI144472 · NIAID · WASHINGTON UNIVERSITY · PI ODOM JOHN, AUDREY RAGAN · 2019 to 2020
$485k
Microbial Origin of Breath Volatile MetabolitesR21AI154370 · NIAID · WASHINGTON UNIVERSITY · PI KAU, ANDREW LEON, ODOM JOHN, AUDREY RAGAN · 2020 to 2021
$473k
TARGETING ISPC TO TREAT MALARIAR21AI123808 · NIAID · WASHINGTON UNIVERSITY · PI ODOM JOHN, AUDREY RAGAN · 2016 to 2017
$440k
SELECTIVE INHIBITION OF THE P. FALCIPARUM GLUCOSE TRANSPORTER PFHTR21AI130584 · NIAID · WASHINGTON UNIVERSITY · PI HRUZ, PAUL W · 2018 to 2019
$419k
NIAID NIH HHS R01 AI103280NIAID NIH HHS R21 AI123808NIAID NIH HHS R21 AI130584NIAID NIH HHS R21 AI144472NIAID NIH HHS R21 AI154370
6 · The paper itself

Abstract

Infection with malarial parasites renders hosts more mosquito-attractive than their uninfected, healthy counterparts. One volatile organic compound, α-pinene, is associated with

Indexed as

MalariaVolatile Organic CompoundsAnimalsErythrocytesHumansTerpenesTerpenesVolatile Organic CompoundsmalariaPlasmodium falciparumsemiochemicalvolatile organic compoundα-pinene

Identifiers

PMID32966041
PMCPMC8543974
OpenAlexW3088295278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.